Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Eurofins Biopharma Product Testing (France)Eurofins Biopharma Product Testing (France)
VS
MerckMerck
Eurofins Biopharma Product Testing (France)

Eurofins Biopharma Product Testing (France)

9 avenue de Laponie, Courtaboeuf, 91978, FR

Last Update: 10/02/2026

View Profile

Eurofins Biopharma Product Testing France is a member of the Eurofins network of laboratories. Eurofins Biopharma Product Testing offers analytical services in GMP environment, with a network of 37 laboratories worldwide (Europe, US, Canada, India, Australia, New Zealan...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:201
Subsidiaries:48
12-month incidents
0
Known data breaches
0
Attack type number
0
Merck

Merck

126 E Lincoln Ave, P.O. Box 2000, Rahway, New Jersey, US, 07065

Last Update: 05/07/2026

View Profile
Between 800 and 849
http://merck.us/2J2xAUh
802/1000Good

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of i...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:44,762
Subsidiaries:2
12-month incidents
0
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Eurofins Biopharma Product Testing (France)

Eurofins Biopharma Product Testing (France)

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Merck

Merck

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins Biopharma Product Testing (France) in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck in 2026.

Incidents

Incident History - Eurofins Biopharma Product Testing (France) (X = Date, Y = Severity)

Eurofins Biopharma Product Testing (France) cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Merck (X = Date, Y = Severity)

Merck cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Eurofins Biopharma Product Testing (France)

Eurofins Biopharma Product Testing (France)

Incidents
No explicit notable incidents reported.
Merck

Merck

Incidents
🔒 Incident : Breach
MER3502435111825
🔒 Incident : Cyber Attack
MER1775377932
🔒 Incident : Cyber Attack
MER1502422

FAQ

Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has the best AI Cybersecurity Score ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has experienced more cyber incidents in the past ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has experienced more cyber incidents this year ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has experienced at least one ransomware attack ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has experienced at least one data breach ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has experienced at least one targeted cyberattack ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has experienced at least one vulnerability ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one holds the most compliance certifications ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one holds the fewest compliance certifications ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has the most subsidiaries ?
Between Eurofins Biopharma Product Testing (France) company and Merck company, which one has the largest number of employees ?
Between Eurofins Biopharma Product Testing (France) and Merck, which company holds both SOC 2 Type 1 certifications ?
Between Eurofins Biopharma Product Testing (France) and Merck, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Eurofins Biopharma Product Testing (France) or Merck ?
Which company is PCI DSS compliant - Eurofins Biopharma Product Testing (France) or Merck ?
Between Eurofins Biopharma Product Testing (France) and Merck, which company complies with HIPAA regulations for healthcare data ?
Between Eurofins Biopharma Product Testing (France) and Merck, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-15511
SUMMARY

A vulnerability was determined in Comfast CF-WR631AX V3 up to 2.7.0.8. Affected by this vulnerability is the function system_wl_upload_pic_file of the file /usr/bin/webmgnt of the component FastCGI Backend. This manipulation of the argument filename causes os command injection. It is possible to initiate the attack remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 9.8)
CVSS2
Base Score: 10.0
Complexity: LOW
AV:N/AC:L/Au:N/C:C/I:C/A:C
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-15510
SUMMARY

A vulnerability was found in Leantime up to 3.8.0. Affected is the function Setting::saveSetting of the component API. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-15509
SUMMARY

A vulnerability has been found in Leantime up to 3.8.0. This impacts the function editUser/addUser of the component JSON-RPC Endpoint. The manipulation of the argument role leads to improper authorization. The attack is possible to be carried out remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-15508
SUMMARY

A flaw has been found in Helicone ai-gateway up to 0.2.0-beta.30. This affects the function build_target_url of the file ai-gateway/src/dispatcher/service.rs of the component AWS Metadata Service. Executing a manipulation of the argument extracted_path_and_query can lead to server-side request forgery. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-15507
SUMMARY

A vulnerability was detected in coollabsio Coolify up to 4.1.1. The impacted element is an unknown function of the file /app/Policies/ of the component Policy Handler. Performing a manipulation results in missing authorization. Remote exploitation of the attack is possible. The exploit is now public and may be used.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8